FindTrial
Sign In

Feasibility Study of Dual-energy CT in Evaluating the Morphology and Function of the Capsule of Chronic Subdural Hematoma

Feasibility Study of Dual-energy CT in Evaluating the Morphology and Function of the Capsule of Chronic Subdural Hematoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600121000
Enrollment
Unknown
Registered
2026-03-24
Start date
2026-03-24
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic subdural hematoma

Interventions

Observation group:N/A

Sponsors

The Affiliated Hospital of Yangzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age>= 18 years old; 2. Meets the diagnostic criteria for CSDH, with CT or MR showing crescent-shaped or semilunar hematoma on the brain surface; 3. Received conventional treatment including medication (such as atorvastatin) or combined burr hole puncture drainage surgery; 4. DECT imaging was performed within one week before treatment.

Exclusion criteria

Exclusion criteria: Patients with acute subdural hematoma, allergy to iodinated contrast agents, severe mental illness, hepatic or renal dysfunction, and those with contraindications to puncture drainage surgery.

Design outcomes

Primary

MeasureTime frame
Hematoma volume;—

Countries

China

Contacts

Public ContactZhenSheng Liu

The Affiliated Hospital of Yangzhou University

zsliu@yzu.edu.cn+86 10 1234 5678

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 4, 2026